BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Dec. 04, 2021	Dec. 05, 2020	Dec. 04, 2021	Dec. 05, 2020
Concentration Risk [Line Items]
Net sales and other revenue	$ 16,728.4	$ 15,408.9	$ 54,503.5	$ 53,918.1
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 16,728.4	$ 15,408.9	$ 54,503.5	$ 53,918.1
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 7,344.2	$ 7,007.9	$ 23,883.0	$ 24,918.3
Percentage of total net sales and other revenue	43.90%	45.50%	43.80%	46.20%
Perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 6,798.0	$ 6,369.7	$ 22,533.8	$ 22,579.4
Percentage of total net sales and other revenue	40.60%	41.30%	41.30%	41.90%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,436.7	$ 1,272.7	$ 4,418.7	$ 3,999.4
Percentage of total net sales and other revenue	8.60%	8.30%	8.10%	7.40%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 906.6	$ 528.9	$ 2,874.4	$ 1,688.9
Percentage of total net sales and other revenue	5.40%	3.40%	5.30%	3.10%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 242.9	$ 229.7	$ 793.6	$ 732.1
Percentage of total net sales and other revenue	1.50%	1.50%	1.50%	1.40%